Option Issue and Appendix 3B
Released
Released
Announcement PDF
ABN 39 151 155 207
21 November 2019
Company Announcements
ASX Limited
Option Issue and Appendix 3B
Estrella Resources Limited (‘the Company’) advises that it has issued 14,000,000 unlisted options to
Directors and employees pursuant to the Company’s Employee Share Option Plan (ESOP) as approved
by shareholders on 26 April 2018. The options are exercisable at $0.03 and expire on 20 November
2022.
The options issued includes 9,000,000 options issued to Directors which were approved by
shareholders at the AGM on 19 November 2019. The Directors have also agreed to issue 5,000,000
options to employees including 2,500,000 options to the Company’s CEO Chris Daws as a means of
providing a performance based incentive to align gains made by key staff and management with
shareholder gains above the exercise price.
Enclosed with this announcement is an Appendix 3B for today’s issue.
For and on behalf of the Board
Christopher J. Daws
Chief Executive Officer
Estrella Resources Limited
__________________________________________________________________________________
Office Address London House, Level 11, 216 St Georges Terrace, PERTH WA 6000 Postal Address GPO Box 2517, PERTH WA 6831
Phone +61 8 9481 0389 Fax +61 8 9463 6103
Email info@estrellaresources.com.au
Page 1 of 1
Appendix 3B
New issue announcement
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12
Name of entity
Estrella Resources Limited
ABN
39 151 155 207
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1
+Class of +securities issued or to be
issued
1) Unlisted Options
2) Unlisted Options
2
Number of +securities issued or to
be issued (if known) or maximum
number which may be issued
1) 9,000,000
2) 5,000,000
3
Principal terms of the +securities
(eg, if options, exercise price and
expiry date; if partly paid
+securities, the amount outstanding
and due dates for payment; if
+convertible
securities,
the
conversion price and dates for
conversion)
1)
2)
Unlisted Options exercisable at $0.03 on or
before 20 November 2022
Unlisted Options exercisable at $0.03 on or
before 20 November 2022
+ See chapter 19 for defined terms.
01/08/2012
Appendix 3B Page 1
Appendix 3B
New issue announcement
4
Do the +securities rank equally in
all respects from the date of
allotment with an existing +class of
quoted +securities?
If the additional securities do not
rank equally, please state:
the date from which they do
the extent to which they
participate for the next
dividend, (in the case of a trust,
distribution) or interest payment
the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
1&2)
No – Upon conversion into ordinary fully paid
shares, the allotted and issued shares will rank
equally in all respects with an existing class of
quoted securities. The options do not entitle the
holder to participate in the next interest or dividend
payment.
5
Issue price or consideration
1) Nil
2) Nil
6
Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly
identify those assets)
1) Issue to Directors (or their nominees) as
approved by shareholders at the Annual
General Meeting on 19 November 2019;
2) Issued to employees (or their nominees) under
the Employee Share Option Plan as approved
by shareholders at the General Meeting held
26 April 2018.
6a
Is the entity an +eligible entity that
has obtained security holder
approval under rule 7.1A?
Yes
If Yes, complete sections 6b – 6h in
relation to the +securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
19 November 2019
6c
Number of +securities issued
without security holder approval
under rule 7.1
N/A
6d
Number of +securities issued with
security holder approval under rule
7.1A
N/A
+ See chapter 19 for defined terms.
Appendix 3B Page 2
01/08/2012
Appendix 3B
New issue announcement
6e
Number of +securities issued with
security holder approval under rule
7.3, or another specific security
holder approval (specify date of
meeting)
6f
Number of securities issued under
an exception in rule 7.2
6g
If securities issued under rule 7.1A,
was issue price at least 75% of 15
day VWAP as calculated under rule
7.1A.3? Include the issue date and
both values. Include the source of
the VWAP calculation.
N/A
6h
If securities were issued under rule
7.1A for non-cash consideration,
state date on which valuation of
consideration was released to ASX
Market Announcements
N/A
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule 19.12).
For example, the issue date for a pro rata
entitlement issue must comply with the applicable
timetable in Appendix 7A.
N/A
1) 9,000,000
2) 5,000,000
Refer Annexure 1
1&2)
21 November 2019
Cross reference: item 33 of Appendix 3B.
8
Number
+Class
Number and +class of all +securities
534,647,797
Ordinary shares
quoted on ASX (including the
securities in section 2 if applicable)
250,980,328
Options exercisable at
$0.05 on or before 27
June 2021
+ See chapter 19 for defined terms.
01/08/2012
Appendix 3B Page 3
Appendix 3B
New issue announcement
9
10
Number and +class of all
+securities not quoted on
ASX
(including
the
securities in section 2 if
applicable)
Dividend policy (in the case
of a trust, distribution
policy) on the increased
capital (interests)
Number
+Class
8,250,000
Options exercisable at $0.024 on or
before 31 March 2020
5,500,000
Options exercisable at $0.05 on or before
15 May 2021
14,000,000
Options exercisable at $0.03 on or before
20 November 2022
N/A
Part 2 - Bonus issue or pro rata issue
11
Is security holder approval required?
12
Is the issue renounceable or nonrenounceable?
13
Ratio in which the +securities will be
offered
14
+Class
15
+Record
of +securities to which the
offer relates
date
to
determine
entitlements
16
Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has +security holders who will
not be sent new issue documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt
acceptances or renunciations
of
+ See chapter 19 for defined terms.
Appendix 3B Page 4
01/08/2012
Appendix 3B
New issue announcement
20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee payable
to brokers who lodge acceptances or
renunciations on behalf of +security
holders
25
If the issue is contingent on +security
holders’ approval, the date of the
meeting
26
Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent to
persons entitled
27
If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do +security holders sell their
entitlements in full through a
broker?
31
How do +security holders sell part of
their entitlements through a broker
and accept for the balance?
32
How do +security holders dispose of
their entitlements (except by sale
through a broker)?
33
+Issue date
+ See chapter 19 for defined terms.
01/08/2012
Appendix 3B Page 5
Appendix 3B
New issue announcement
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34
Type of securities
(tick one)
(a)
Securities described in Part 1
(b)
All other securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee
incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35
If the securities are equity securities, the names of the 20 largest holders of the
additional securities, and the number and percentage of additional securities held by
+
+
+
+
those holders
36
If the securities are equity securities, a distribution schedule of the additional
securities setting out the number of holders in the categories
+
+
+
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37
+
A copy of any trust deed for the additional securities
Entities that have ticked box 34(b)
38
Number of securities for which +quotation is sought
39
Class of +securities for which quotation is sought
+ See chapter 19 for defined terms.
Appendix 3B Page 6
01/08/2012
Appendix 3B
New issue announcement
40
Do the +securities rank equally in all respects from
the date of allotment with an existing +class of
quoted +securities?
If the additional securities do not rank equally,
please state:
the date from which they do
the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
the extent to which they do not rank equally,
other than in relation to the next dividend,
distribution or interest payment
41
Reason for request for quotation now
Example: In the case of restricted securities, end of restriction period
(if issued upon conversion of another security,
clearly identify that other security)
Number
42
+Class
Number and +class of all +securities quoted on ASX
(including the securities in clause 38)
Quotation agreement
1
+Quotation of our additional +securities is in ASX’s absolute discretion.
ASX may
quote the +securities on any conditions it decides.
2
We warrant the following to ASX.
The issue of the +securities to be quoted complies with the law and is not for
an illegal purpose.
There is no reason why those +securities should not be granted +quotation.
An offer of the +securities for sale within 12 months after their issue will not
require disclosure under section 707(3) or section 1012C(6) of the
Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give
this warranty
Section 724 or section 1016E of the Corporations Act does not apply to any
applications received by us in relation to any +securities to be quoted and that
no-one has any right to return any +securities to be quoted under sections 737,
738 or 1016F of the Corporations Act at the time that we request that the
+securities be quoted.
+ See chapter 19 for defined terms.
01/08/2012
Appendix 3B Page 7
Appendix 3B
New issue announcement
If we are a trust, we warrant that no person has the right to return the
+securities to be quoted under section 1019B of the Corporations Act at the
time that we request that the +securities be quoted.
3
We will indemnify ASX to the fullest extent permitted by law in respect of any claim,
action or expense arising from or connected with any breach of the warranties in this
agreement.
4
We give ASX the information and documents required by this form. If any
information or document not available now, will give it to ASX before +quotation of
the +securities begins. We acknowledge that ASX is relying on the information and
documents. We warrant that they are (will be) true and complete.
Sign here:
David McEntaggart
(Company Secretary)
Date
21 November 2019
Print name:
+ See chapter 19 for defined terms.
Appendix 3B Page 8
01/08/2012
Appendix 3B
New issue announcement
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and
rule 7.1A for +eligible entities
Introduced 01/08/12
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid ordinary
securities on issue 12 months before date
of issue or agreement to issue
491,883,292
Add the following: (All issues converted to
post consolidation)
•
Number of fully paid ordinary securities
issued in that 12 month period under
an exception in rule 7.2
•
Number of fully paid ordinary securities
issued in that 12 month period with
shareholder approval
•
Number of partly paid ordinary
securities that became fully paid in that
12 month period
38,500,000 fully paid shares (issued 27
March 2019, ratified 19 November 2019)
3,464,505 fully paid shares (issued 16
August 2019, ratified 19 November 2019)
800,000 fully paid shares (issued 20
August 2019, ratified 19 November 2019)
Note:
• Include only ordinary securities here –
other classes of equity securities
cannot be added
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
Subtract the number of fully paid ordinary
securities cancelled during that 12 month
period
-
“A”
534,647,797
+ See chapter 19 for defined terms.
01/08/2012
Appendix 3B Page 9
Appendix 3B
New issue announcement
Step 2: Calculate 15% of “A”
“B”
0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15
80,197,169
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
•
Under an exception in rule 7.2
•
Under rule 7.1A
•
With security holder approval under
rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable ) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
“C”
-
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
80,197,169
Note: number must be same as shown in
Step 2
Subtract “C”
-
Note: number must be same as shown in
Step 3
Total [“A” x 0.15] – “C”
80,197,169
[Note: this is the remaining placement
capacity under rule 7.1]
+ See chapter 19 for defined terms.
Appendix 3B Page 10
01/08/2012
Appendix 3B
New issue announcement
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
534,647,797
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D”
0.10
Note: this value cannot be changed
Multiply “A” by 0.10
53,464,779
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as
separate line items
“E”
-
+ See chapter 19 for defined terms.
01/08/2012
Appendix 3B Page 11
Appendix 3B
New issue announcement
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
53,464,779
Note: number must be same as shown in
Step 2
Subtract “E”
-
Note: number must be same as shown in
Step 3
Total [“A” x 0.10] – “E”
53,464,779
Note: this is the remaining placement
capacity under rule 7.1A
+ See chapter 19 for defined terms.
Appendix 3B Page 12
01/08/2012
Share your feedback
Discover